Literature DB >> 12032101

Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure.

Tsutomu Kazumi1, Akira Kawaguchi, Keiko Sakai, Tsutomu Hirano, Gen Yoshino.   

Abstract

OBJECTIVE: Three measures--heart rate, a global index of the influence of the autonomic nervous system on the heart; circulating concentrations of adiponectin, an adipose-specific protein; and C-reactive protein (CRP), a sensitive marker of inflammation--have been reported to be closely associated with insulin resistance. Patients with borderline hypertension are known to be more insulin resistant and dyslipidemic than those with normal blood pressure (BP). BP can be classified into three categories: optimal, normal, and high-normal. The present study examined whether those with high-normal BP have any of these three conditions as compared with those with optimal BP in young healthy men. RESEARCH DESIGN AND METHODS: Anthropometric, blood pressure, heart rate, and blood tests, including tests for adiponectin and CRP, were conducted in 198 male students, ages 18-26 years, who had fasted overnight. Insulin resistance (IR) and insulin secretion (beta-cell levels) were calculated using the homeostasis model assessment (HOMA), and LDL size was measured by PAGE.
RESULTS: Compared with the 90 men who had optimal BP, the 46 men with high-normal BP had increased heart rate, BMI, percent body fat, and serum leptin levels. In addition, they had greater serum insulin, HOMA IR, and beta-cell levels, lower adiponectin levels, and comparable CRP levels. Furthermore, the 46 men with high-normal BP had higher serum triglyceride and apolipoprotein (apo) B levels, and smaller LDL size; however, there was no difference in LDL and HDL cholesterol and apoA-I between men with optimal and high-normal BP. After adjusting for BMI, differences were still significant in serum adiponectin, heart rate, and LDL particle size. As BP rose, there was an increase in heart rate (BMI-adjusted least square means were 63, 65, and 70 bpm in men with optimal, normal, and high-normal BP, respectively; P = 0.005), whereas serum adiponectin (7.5, 6.6, and 6.4 mg/l; P = 0.007) and LDL particle size (271, 269, and 269 A; P = 0.008) decreased.
CONCLUSIONS: Young men with high-normal BP have a faster heart rate, lower serum adiponectin levels, and smaller LDL size than men with optimal BP, even after adjustment for BMI. These results suggest the necessity of preventing further development of cardiac and metabolic diseases in young people who have high-normal BP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032101     DOI: 10.2337/diacare.25.6.971

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  53 in total

1.  Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents.

Authors:  Javier De Las Heras; Sojung Lee; Fida Bacha; Hala Tfayli; Silva Arslanian
Journal:  Horm Res Paediatr       Date:  2011-09-30       Impact factor: 2.852

2.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

Review 3.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

4.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

5.  Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

Authors:  Katarzyna Dunajska; Andrzej Milewicz; Diana Jedrzejuk; Jadwiga Szymczak; Wiktor Kuliczkowski; Piotr Salomon; Dariusz Bialy; Karol Poczatek; Przemysław Nowicki
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 6.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

7.  The pathophysiological mechanisms of GERD in the obese patient.

Authors:  Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

8.  Remarkable features of ovarian morphology and reproductive hormones in insulin-resistant Zucker fatty (fa/fa) rats.

Authors:  Hiroyuki Honnma; Toshiaki Endo; Tamotsu Kiya; Ayumi Shimizu; Kunihiko Nagasawa; Tsuyoshi Baba; Takashi Fujimoto; Hirofumi Henmi; Yoshimitsu Kitajima; Kengo Manase; Shinichi Ishioka; Eiki Ito; Tsuyoshi Saito
Journal:  Reprod Biol Endocrinol       Date:  2010-06-24       Impact factor: 5.211

9.  Adiponectin and IL-6: Mediators of inflammation in progression of healthy to type 2 diabetes in Indian population.

Authors:  Smitha Upadhyaya; Vinitha Kadamkode; Rafi Mahammed; Chandraprabha Doraiswami; Gautam Banerjee
Journal:  Adipocyte       Date:  2013-10-08       Impact factor: 4.534

Review 10.  Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.

Authors:  Eduardo Esteve; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.